Antibacterials that are used as growth promoters in animal husbandry can affect the release of Shiga-toxin-2-converting bacteriophages and Shiga toxin 2 from Escherichia coli strains

Microbiology

Volumn 146, Issue 5, 2000, Pages 1085-1090

  Köhler, Bernd ^a   Karch, Helge ^a   Schmidt, Herbert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Antibacterial growth promoters; E. coli O157; Phage induction; Shiga toxin release; Shiga toxin converting bacteriophages

Indexed keywords

ANTIBIOTIC AGENT; CARBADOX; GROWTH PROMOTOR; MONENSIN; OLAQUINDOX; SHIGA TOXIN; TYLOSIN;

AGRICULTURE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE; BACTERIUM CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; INTESTINE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; UNIDENTIFIED BACTERIOPHAGE;

EID: 0041908165     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-146-5-1085     Document Type: Article

References (30)

1. Beutin, L., Geier, D., Zimmermann, S. & Karch, H. (1995). Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol 33, 631-615.
2. Brunder, W., Schmidt, H., Frosch, M. & Karch, H. (1999). The large plasmids of Shiga-toxm-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology 145, 1005-1014.
3. CDC (1982). Isolation of E. coli O157: H7 from sporadic cases of hemorrhagic colitis - United States. Morb Mortal Wkly Rep 31, 580-585.
4. Fuchs, S., Mühldorfer, I., Donohue-Rolfe, A., Kerényi, M., Emödy, L., Rossen, A., Alexiev, R., Nenkov, P. & Hacker, J. (1999). Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Microb Pathog 27, 13-23.
5. de Graaf, G. J., Jager, L. P., Baars, A. J. & Spierenburg, Th. J. (1988). Some pharmacokinetic observations of carbadox medication in pigs. Vet Q 10, 34-41.
6. Greife, H. A. & Berschauer, F. (1988). Leistungsförderer in der Tierproduktion: Stand und Perspektiven. Übers Tierernährg 16, 27-78.
7. Grif, K., Dierich, M. P., Karch, H. & Allerberger, F. (1998). Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis 17, 761-766.
8. Griffin, P. M. & Tauxe, R. V. (1991). The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13, 60-98.
9. Gunzer, F., Böhm, H., Rüssmann, H., Bitzan, M., Aleksic, S. & Karch, H. (1992). Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. K Clin Microbiol 30, 1807-1810.
10. Jacewicz, M. S., Acheson, D. W., Binion, D. G., West, G. A., Lincicome, L. L., Fiocehi, C. & Keusch, G. T. (1999). Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect Immun 67, 1439-1444.
11. Matsushiro, A., Sato, K., Miyamoto, H., Yamamura, T. & Honda, T. (1999). Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin. J Bacteriol 181, 2257-2260.
12. Moore, P. R., Evenson, A., Luckey, T. D., McCoy, E., Elvehjem, C. A. & Hart, E. B. (1946). Use of sulfasuxidine, streptothricin and streptomycin in nutritional studies with the chick. J Biol Chem 16, 437.
13. Mühldorfer, I., Hacker, J., Keusch, G. T., Acheson, D. W., Tschäpe, H., Kane, A. V., Ritter, A., Ölschläger, T. & Donohue-Rolfe, A. (1996). Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun 64, 495-502.
14. National Committee for Clinical Laboratory Standards (1993). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A3. Villanova, PA: National Commitee for Clinical Laboratory Standards.
15. Neely, M. N. & Friedman, D. I. (1998). Functional and genetic analysis of regulatory regions of coliphage H-19B: location of Shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol Microbiol 28, 1255-1267.
16. Ostroff, S. M., Griffin, P. M., Tauxe, R. V., Shipman, L. D., Greene, K. D., Wells, J. G., Lewis, J. H., Blake, P. A. & Kobayashi, J. M. (1990). A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol 132, 239-247.
17. Pierard, D., Muyldermans, G., Moriau, L., Stevens, D. & Lauwers, S. (1998). Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol 36, 3317-3322.
18. Richter, H., Klie, H., Timm, M., Gallien, P., Steinrück, H., Perlberg, K. W. & Protz, D. (1997). Verotoxin-producing E. coli (VTEC) in fcccs from cattle slaughtered in Germany. Berl Münch Tierärztl Wochenschr 110, 121-127.
19. Riedel-Caspary, G. (1986). Leistungsförderer in der Schweinemast. DLG-Mitteilung 11, 608-619.
20. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
21. Schmidt, H., Geitz, C., Tarr, P. l., Frosch, M. & Karch, H. (1999a). Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J Infect Dis 179, 115-123.
22. Schmidt, H., Scheef, J., Huppertz, H. I., Frosch, M. & Karch, H. (1999b). Escherichia coli O157:H7 and O157:H strains that do not produce Shiga toxin: phenotypic and genotypic characterization of isolates asscoiated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 37, 3491-3496.
23. Smith, H. W., Green, P. & Parsell, Z. (1983). Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol 129, 3121-3137.
24. Spierenburg, Th. J., van Lenthe, H., de Graaf, G. & Jager, L. P. (1988). Liquid chromatographic determination of olaquindox in medicated feeds and in contents of porcine gastrointestinal tract. J Assoc Off Anal Chem 71, 1106-1109.
25. Strockbine, N. A., Marques, L R., Newland, J. W., Smith, H. W., Holmes, R. K. & O'Brien, A. D. (1986). Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 53, 135-140.
26. Strockbine, N. A., Wells, J. G., Bopp, C. A. & Barrett, T. J. (1998). Overview of detection and subtyping methods. In Escherichia coli O157:H7 and Other Shiga Toxin-producing E. coli Strains, pp. 331-356. Edited by J. B. Kaper & A. D. O'Brien. Washington, DC: American Society for Microbiology.
27. Trevena, W. B., Hooper, R. S., Wray, C., Willshaw, G. A., Cheasty, T. & Domingue, G. (1996). Vero cytotoxin-producing Escherichia coli O157 associated with companion animals. Vet Rec 138, 400.
28. Watanabe, H., Wada, A., Inagaki, Y., Itoh, K. & Tamura, K. (1996). Outbreaks of enterohaemorrhagic Escherichia coli O157:H7 infection by two different genotype strains in Japan, 1996. Lancet 348, 831-832.
29. Williams, J. M., Boyd, B., Nutikka, A., Lingwood, C. A., Barnett, F. D., Milford, D. V. & Taylor, C. M. (1999). A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol Lett 105, 47-57.
30. Witte, W. (1998). Medical consequences of antibiotic use in agriculture. Science 279, 996-997.